{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T01:15:14Z","timestamp":1773796514175,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,9,16]],"date-time":"2010-09-16T00:00:00Z","timestamp":1284595200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Virol J"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1186\/1743-422x-7-240","type":"journal-article","created":{"date-parts":[[2010,9,16]],"date-time":"2010-09-16T14:15:44Z","timestamp":1284646544000},"source":"Crossref","is-referenced-by-count":32,"title":["Assessing changes in vascular permeability in a hamster model of viral hemorrhagic fever"],"prefix":"10.1186","volume":"7","author":[{"given":"Brian B","family":"Gowen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justin G","family":"Julander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nyall R","family":"London","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min-Hui","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deanna","family":"Larson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John D","family":"Morrey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dean Y","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mike","family":"Bray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,9,16]]},"reference":[{"key":"985_CR1","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.coi.2005.05.001","volume":"17","author":"M Bray","year":"2005","unstructured":"Bray M: Pathogenesis of viral hemorrhagic fever. Curr Opin Immunol 2005, 17: 399-403. 10.1016\/j.coi.2005.05.001","journal-title":"Curr Opin Immunol"},{"key":"985_CR2","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1055\/s-0037-1616926","volume":"28","author":"P Aleksandrowicz","year":"2008","unstructured":"Aleksandrowicz P, Wolf K, Falzarano D, Feldmann H, Seebach J, Schnittler H: Viral haemorrhagic fever and vascular alterations. Hamostaseologie 2008, 28: 77-84.","journal-title":"Hamostaseologie"},{"key":"985_CR3","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1128\/CMR.11.3.480","volume":"11","author":"DJ Gubler","year":"1998","unstructured":"Gubler DJ: Dengue and dengue hemorrhagic fever. Clin Microbiol Rev 1998, 11: 480-496.","journal-title":"Clin Microbiol Rev"},{"key":"985_CR4","doi-asserted-by":"crossref","first-page":"370","DOI":"10.4269\/ajtmh.2008.78.370","volume":"78","author":"LA Villar-Centeno","year":"2008","unstructured":"Villar-Centeno LA, Diaz-Quijano FA, Martinez-Vega RA: Biochemical alterations as markers of dengue hemorrhagic fever. Am J Trop Med Hyg 2008, 78: 370-374.","journal-title":"Am J Trop Med Hyg"},{"key":"985_CR5","doi-asserted-by":"publisher","first-page":"10208","DOI":"10.1128\/JVI.00062-06","volume":"80","author":"S Shresta","year":"2006","unstructured":"Shresta S, Sharar KL, Prigozhin DM, Beatty PR, Harris E: Murine model for dengue virus-induced lethal disease with increased vascular permeability. J Virol 2006, 80: 10208-10217. 10.1128\/JVI.00062-06","journal-title":"J Virol"},{"key":"985_CR6","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/nature07013","volume":"453","author":"ST Chen","year":"2008","unstructured":"Chen ST, Lin YL, Huang MT, Wu MF, Cheng SC, Lei HY, Lee CK, Chiou TW, Wong CH, Hsieh SL: CLEC5A is critical for dengue-virus-induced lethal disease. Nature 2008, 453: 672-676. 10.1038\/nature07013","journal-title":"Nature"},{"key":"985_CR7","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1172\/JCI100859","volume":"16","author":"JG Gibson","year":"1937","unstructured":"Gibson JG, Evans WA: Clinical Studies of the Blood Volume. I. Clinical Application of a Method Employing the Azo Dye \"Evans Blue\" and the Spectrophotometer. J Clin Invest 1937, 16: 301-316. 10.1172\/JCI100859","journal-title":"J Clin Invest"},{"key":"985_CR8","first-page":"547","volume":"16","author":"LG Rowntree","year":"1915","unstructured":"Rowntree LG, Geraghty JT: A method for determination of plasma and blood volume. Arch Intern Med 1915, 16: 547-557.","journal-title":"Arch Intern Med"},{"key":"985_CR9","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1084\/jem.20040915","volume":"200","author":"LF Thompson","year":"2004","unstructured":"Thompson LF, Eltzschig HK, Ibla JC, Van De Wiele CJ, Resta R, Morote-Garcia JC, Colgan SP: Crucial role for ecto-5'-nucleotidase (CD73) in vascular leakage during hypoxia. J Exp Med 2004, 200: 1395-1405. 10.1084\/jem.20040915","journal-title":"J Exp Med"},{"key":"985_CR10","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.antiviral.2007.10.002","volume":"78","author":"BB Gowen","year":"2008","unstructured":"Gowen BB, Holbrook MR: Animal models of highly pathogenic RNA viral infections: hemorrhagic fever viruses. Antiviral Res 2008, 78: 79-90. 10.1016\/j.antiviral.2007.10.002","journal-title":"Antiviral Res"},{"key":"985_CR11","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/laban0108-26","volume":"37","author":"CD Steel","year":"2008","unstructured":"Steel CD, Stephens AL, Hahto SM, Singletary SJ, Ciavarra RP: Comparison of the lateral tail vein and the retro-orbital venous sinus as routes of intravenous drug delivery in a transgenic mouse model. Lab Anim (NY) 2008, 37: 26-32. 10.1038\/laban0108-26","journal-title":"Lab Anim (NY)"},{"key":"985_CR12","doi-asserted-by":"publisher","first-page":"e3725","DOI":"10.1371\/journal.pone.0003725","volume":"3","author":"BB Gowen","year":"2008","unstructured":"Gowen BB, Smee DF, Wong MH, Hall JO, Jung KH, Bailey KW, Stevens JR, Furuta Y, Morrey JD: Treatment of late stage disease in a model of arenaviral hemorrhagic fever: T-705 efficacy and reduced toxicity suggests an alternative to ribavirin. PLoS One 2008, 3: e3725. 10.1371\/journal.pone.0003725","journal-title":"PLoS One"},{"key":"985_CR13","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.4269\/ajtmh.2006.74.1096","volume":"74","author":"E Sbrana","year":"2006","unstructured":"Sbrana E, Mateo RI, Xiao SY, Popov VL, Newman PC, Tesh RB: Clinical laboratory, virologic, and pathologic changes in hamsters experimentally infected with Pirital virus (Arenaviridae): a rodent model of Lassa fever. Am J Trop Med Hyg 2006, 74: 1096-1102.","journal-title":"Am J Trop Med Hyg"},{"key":"985_CR14","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.antiviral.2006.08.008","volume":"73","author":"JG Julander","year":"2007","unstructured":"Julander JG, Morrey JD, Blatt LM, Shafer K, Sidwell RW: Comparison of the inhibitory effects of interferon alfacon-1 and ribavirin on yellow fever virus infection in a hamster model. Antiviral Res 2007, 73: 140-146. 10.1016\/j.antiviral.2006.08.008","journal-title":"Antiviral Res"},{"key":"985_CR15","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.4269\/ajtmh.2006.74.1084","volume":"74","author":"E Sbrana","year":"2006","unstructured":"Sbrana E, Xiao SY, Popov VL, Newman PC, Tesh RB: Experimental yellow fever virus infection in the golden hamster (Mesocricetus auratus) III. Clinical laboratory values. Am J Trop Med Hyg 2006, 74: 1084-1089.","journal-title":"Am J Trop Med Hyg"},{"key":"985_CR16","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1056\/NEJM198601023140104","volume":"314","author":"JB McCormick","year":"1986","unstructured":"McCormick JB, King IJ, Webb PA, Scribner CL, Craven RB, Johnson KM, Elliott LH, Belmont-Williams R: Lassa fever. Effective therapy with ribavirin. N Engl J Med 1986, 314: 20-26. 10.1056\/NEJM198601023140104","journal-title":"N Engl J Med"},{"key":"985_CR17","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1128\/AAC.01494-06","volume":"51","author":"JG Julander","year":"2007","unstructured":"Julander JG, Furuta Y, Shafer K, Sidwell RW: Activity of T-1106 in a hamster model of yellow Fever virus infection. Antimicrob Agents Chemother 2007, 51: 1962-1966. 10.1128\/AAC.01494-06","journal-title":"Antimicrob Agents Chemother"},{"key":"985_CR18","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1086\/320199","volume":"183","author":"RB Tesh","year":"2001","unstructured":"Tesh RB, Guzman H, da Rosa AP, Vasconcelos PF, Dias LB, Bunnell JE, Zhang H, Xiao SY: Experimental yellow fever virus infection in the Golden Hamster (Mesocricetus auratus). I. Virologic, biochemical, and immunologic studies. J Infect Dis 2001, 183: 1431-1436. 10.1086\/320199","journal-title":"J Infect Dis"},{"key":"985_CR19","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s10456-009-9130-z","volume":"12","author":"NR London","year":"2009","unstructured":"London NR, Whitehead KJ, Li DY: Endogenous endothelial cell signaling systems maintain vascular stability. Angiogenesis 2009, 12: 149-158. 10.1007\/s10456-009-9130-z","journal-title":"Angiogenesis"},{"key":"985_CR20","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1002\/ijc.2910370318","volume":"37","author":"J Balzarini","year":"1986","unstructured":"Balzarini J, Mitsuya H, De Clercq E, Broder S: Comparative inhibitory effects of suramin and other selected compounds on the infectivity and replication of human T-cell lymphotropic virus (HTLV-III)\/lymphadenopathy-associated virus (LAV). Int J Cancer 1986, 37: 451-457. 10.1002\/ijc.2910370318","journal-title":"Int J Cancer"},{"key":"985_CR21","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1089\/aid.1991.7.537","volume":"7","author":"R Pal","year":"1991","unstructured":"Pal R, Mumbauer S, Hoke G, Larocca R, Myers C, Sarngadharan MG, Stein CA: Effect of Evans blue and trypan blue on syncytia formation and infectivity of human immunodeficiency virus type I and type II in vitro. AIDS Res Hum Retroviruses 1991, 7: 537-543. 10.1089\/aid.1991.7.537","journal-title":"AIDS Res Hum Retroviruses"},{"key":"985_CR22","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/0042-6822(90)90440-3","volume":"175","author":"D Schols","year":"1990","unstructured":"Schols D, Pauwels R, Desmyter J, De Clercq E: Dextran sulfate and other polyanionic anti-HIV compounds specifically interact with the viral gp120 glycoprotein expressed by T-cells persistently infected with HIV-1. Virology 1990, 175: 556-561. 10.1016\/0042-6822(90)90440-3","journal-title":"Virology"},{"key":"985_CR23","doi-asserted-by":"publisher","first-page":"S110","DOI":"10.1038\/nm1142","volume":"10","author":"TW Geisbert","year":"2004","unstructured":"Geisbert TW, Jahrling PB: Exotic emerging viral diseases: progress and challenges. Nat Med 2004, 10: S110-121. 10.1038\/nm1142","journal-title":"Nat Med"},{"key":"985_CR24","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1055\/s-0037-1613397","volume":"89","author":"HJ Schnittler","year":"2003","unstructured":"Schnittler HJ, Feldmann H: Viral hemorrhagic fever--a vascular disease? Thromb Haemost 2003, 89: 967-972.","journal-title":"Thromb Haemost"},{"key":"985_CR25","doi-asserted-by":"crossref","first-page":"23ra19","DOI":"10.1126\/scitranslmed.3000678","volume":"2","author":"NR London","year":"2010","unstructured":"London NR, Zhu W, Bozza FA, Smith MC, Greif DM, Sorensen LK, Chen L, Kaminoh Y, Chan AC, Passi SF, et al.: Targeting Robo4-dependent slit signaling to survive the cytokine storm in sepsis and influenza. Sci Transl Med 2010, 2: 23ra19.","journal-title":"Sci Transl Med"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1743-422X-7-240.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1743-422X-7-240\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1743-422X-7-240.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T16:20:39Z","timestamp":1548174039000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/1743-422X-7-240"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9,16]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["985"],"URL":"https:\/\/doi.org\/10.1186\/1743-422x-7-240","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,9,16]]},"article-number":"240"}}